Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareFRA:VIJ +0.98%93 PS Ratio is 1.69 as of Jul. 21, 2026, which is 18% below its 10-year median of 2.06. GuruFocus rates FRA:VIJ with a GF Score™ of 93/100 and a GF Value™ of €9.43 (Fairly Valued). The stock has 7 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 65.92% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Viemed Healthcare's share price is €10.30.
Viemed Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €6.08. Hence, Viemed Healthcare's PS Ratio for today is 1.69.
Warning Sign:
Viemed Healthcare Inc stock PS Ratio (=1.69) is close to 2-year high of 1.75.
The historical rank and industry rank for Viemed Healthcare's PS Ratio or its related term are showing as below:
FRA:VIJ'
s PS Ratio Range Over the Past 10 Years
Min: 1.01 Med: 2.06 Max: 5.23
Current: 1.69
During the past 10 years, Viemed Healthcare's highest PS Ratio was 5.23. The lowest was 1.01. And the median was 2.06.
FRA:VIJ's PS Ratio is ranked better than 65.92% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.845
vs FRA:VIJ: 1.69
During the past 12 months, the average Revenue per Share Growth Rate of Viemed Healthcare was 24.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 23.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 17.90% per year.
During the past 10 years, Viemed Healthcare's highest 3-Year average Revenue per Share Growth Rate was 37.90% per year. The lowest was 11.80% per year. And the median was 23.80% per year.
Back to Basics: PS Ratio
Viemed Healthcare (FRA:VIJ) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Viemed Healthcare PS Ratio Related Terms
Viemed Healthcare PS Ratio Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Viemed Healthcare's Share Price of today is €10.30. Viemed Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Viemed Healthcare (FRA:VIJ) has a PS Ratio of 1.69 as of Jul. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Viemed Healthcare and its competitors. This is 18% below median its historical median of 2.06. Over the past decade, Viemed Healthcare's PS Ratio has ranged from 1.01 to 5.23. According to the industry distribution chart, Viemed Healthcare ranks #274 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 34.1%.
Is Viemed Healthcare's PS Ratio too high?
Viemed Healthcare's current PS Ratio of 1.69 is 18% below median its 10-year median of 2.06. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 5.23. The Medical Devices & Instruments industry median PS Ratio is 2.85. Viemed Healthcare's value of 1.69 is 40.6% below this industry median. Based on the distribution chart, Viemed Healthcare ranks #274 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's PS Ratio compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #274 out of 804 companies for PS Ratio. This puts Viemed Healthcare in the upper half of its industry. The industry median PS Ratio is 2.85. Viemed Healthcare's value of 1.69 is 40.6% below this benchmark. Historically, Viemed Healthcare's own PS Ratio has ranged from 1.01 to 5.23 over the past decade. While the company's 10-year median is 2.06 vs. the industry median of 2.85, Viemed Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.85, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current PS Ratio of 1.69 is 40.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current PS Ratio is 1.69, which is 18% below median its own 10-year median of 2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (FRA:VIJ) is currently considered Fairly Valued. The stock's GF Value™ is €9.43, compared to a current price of €10.30 — trading 9.2% above its estimated fair value. The current PS Ratio is 1.69, which is 18% below median its 10-year median of 2.06 and 40.6% below the Medical Devices & Instruments industry median of 2.85. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Viemed Healthcare (FRA:VIJ), the current PS Ratio is 1.69 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (FRA:VIJ) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of €10.30 is trading 9.2% above its estimated GF Value™ of €9.43.
GuruFocus considers Viemed Healthcare to be Fairly Valued.
Key valuation signals for FRA:VIJ:
PS Ratio: 1.69 (18% below median its 10-year median of 2.06)
GF Value™: €9.43 vs. price of €10.30 (9.2% above fair value)
Industry Position: 40.6% below the Medical Devices & Instruments median (#274 of 804)
No single metric tells the full story. See the FRA:VIJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score
Get the complete analysis for FRA:VIJ
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VIJ has been successfully added to your 
